TB Research

Exploration of pyrazole-based pyridine-4-carbohydrazide derivatives as drug-resistant <i>Mtb</i> agents: design, synthesis, biological evaluation, and <i>in-silico</i> studies

Pardeep Kumar, Pradip Malik, Juned Ali, Deepanshi Saxena, Anuradha Singampalli, Rani Bandela, Sri Mounika Bellapukonda, Sugali Indravath Rajyalakshmi, et al. (14 authors)

Future Medicinal Chemistry · 2025-06

Abstract

BACKGROUND: is the need of the hour to combat tuberculosis (TB) disease. MATERIALS AND METHODS: Rv and drug-resistant TB strains. Time kill kinetics assay was performed to check bactericidal/bacteriostatic effect, molecular docking, dynamics simulation over 100 ns was performed against enoyl acyl carrier protein reductase (InhA) along with QSAR, ADMET profile prediction. RESULTS: g/mL. CONCLUSION: The pyrazole clubbed with pyridine-4-carbohydrazide is a potential scaffold for further exploration as anti-TB agent.

MeSH terms

  • Pyrazole
  • Mycobacterium tuberculosis
  • In silico
  • Chemistry
  • INHA
  • Rifampicin
  • Ethambutol
  • Isoniazid
  • Carbohydrazide
  • Tuberculosis
  • Combinatorial chemistry
  • Docking (animal)
  • Drug
  • Pharmacology
  • Stereochemistry